Resveratrol attenuates morphine antinociceptive tolerance via SIRT1 regulation in the rat spinal cord-Reference-Cited by-同舟云学术

Resveratrol attenuates morphine antinociceptive tolerance via SIRT1 regulation in the rat spinal cord

Published:2014-04 Issue: Volume:566 Page:55-60
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

He Xin,Ou Peng,Wu Kemin,Huang Changsheng,Wang Yichun,Yu Zou,Guo Qulian

Publisher

Elsevier BV

Subject

General Neuroscience

Reference34 articles.

1. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids;Kest;J. Pharmacol. Exp. Ther.,1997

2. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions;Mayer;Proc. Natl. Acad. Sci. U. S. A.,1999

3. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists;Powell;Br. J. Pharmacol.,2000

4. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia;Cortinez;Br. J. Anaesth.,2001

5. p300 exerts an epigenetic role in chronic neuropathic pain through its acetyltransferase activity in rats following chronic constriction injury (CCI);Zhu;Mol. Pain,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Understanding of DNA Methylation in the Pathogenesis of Neuropathic Pain;Mechanism and Genetic Susceptibility of Neurological Disorders;2024

2. Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance;Phytotherapy Research;2023-10-05

3. Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosis;Journal of Pharmaceutical Analysis;2023-10

4. β_lactam antibiotics against drug addiction: A novel therapeutic option;Drug Development Research;2023-08-21

5. Dietary polyphenols drive dose-dependent behavioral and molecular alterations to repeated morphine;Scientific Reports;2023-07-27